In this episode, Clifton Flack, founder, and CEO of CiiTech, reveals a revolutionary approach to weight loss that’s not centered around appetite suppression. CiiTech is conducting research centered around Fatty Liver Disease, Obesity, and Diabetes. Once patent approval is attained, Ciitech will launch a food supplement version of their unique cannabinoid formulation, while continuing the clinical studies to complete and launch a pharma version of the treatment. Learn about their unique approach and two-pronged mechanism in today’s podcast. Interestingly, though CiiTech currently sells and distributes its line of food supplements in the UK, Clifton has chosen to conduct the research and clinical studies in Israel. In his words: “in addition to Israel’s vast data & experience in medical cannabis research and Israel’s medical innovation mentality, costs of the entire process are significantly more attractive in Israel.” POTENTIAL GLOBAL DISTRIBUTORS interested in distributing the food supplement version, as well as SMART INVESTORS that can add value to the pharma solution are invited to reach out to Clifton at: clifton@ciitech.co.uk https://ciitech.co.il/
Special thanks to Ehud Yerushalmi, our sound editor.